Back to EGX

Ibnsina Pharma Co SAE stock price and financial data

Egypt · Health Care · Health Care Providers & Services · EGP

Prepare your investment and research the stock. Ibnsina Pharma Co SAE (ISPH.CA), EGX : share price and history, results and fundamentals, analysis tools and peer companies.

An investment account is required to buy shares. Demo mode uses virtual money: no order is sent to the market.

Price history

Price as of 31 Dec 2025 11.72 EGP
Last change +0.60% 7D change +2.81%

Issuer profile

Ibnsina Pharma Co SAE is an Egypt-based drug retailers business in the consumer non-cyclicals sector, listed on the Egyptian Exchange under ticker ISPH.CA. Ibnsina Pharma Co is an Egypt-based pharmaceutical distribution company. Ibnsina Pharma Co SAE distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers. Ibnsina Pharma Co's nationwide distribution network with more than 50 operational sites, including distribution hubs and central warehouses, is supported by a fleet of approximately 600 vehicles. Ibnsina Pharma Co SAE's main services for suppliers include management of warehousing and logistics for pharmaceutical products as well as the development and execution of tailored marketing solutions targeting a nationwide database of customers. Its investment profile is best assessed through consumer demand, distribution reach, product availability, purchasing power, and operating efficiency in Egypt. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.

Fundamentals

connect to view more

Sign in to unlock the full fundamentals history.

Sign in
Metric  (EGP, B) 2025 2024 2023 2022 2021
Revenue Total Revenue 76.79
EBITDA 3.89
EBIT 3.56
Net income Net Income 1.05
Net margin 1.36%